| 公司简称：宏川智慧 股票代码：002930 | | --- | | 是否存在 | | 序 该事项（是 号 事项 备注 | | /否/不适 | | 用） | | 上市公司合规性要求 | | 最近一个会计年度财务会计报告是否未被注册会计 | | 是 | | 最近一个会计年度财务报告内部控制是否未被注册 | | 是 | | 上市后最近36个月内是否未出现过未按法律法规、 | | 是 | | 是否未为激励对象提供贷款以及其他任何形式的财 | | 是 | | 激励对象合规性要求 | | 是否未包括单独或合计持有上市公司5%以上股份的 | | 是 | | 是否最近12个月内未被证券交易所认定为不适当人 | | 是 | | 是否最近12个月内未被中国证监会及其派出机构认 | | 是 | | 是否最近12个月内未因重大违法违规行为被中国证 | | 是 | | 是否不存在《公司法》规定的不得担任公司董事、 | | 高级管理人员情形 | | 激励计划合规性要求 | | 上市公司全部在有效期内的股权激励计划所涉及的 | | 是 | | 单一激励对象通过全部在有效期内的股权激励计划 | | 是 | | 激励对象预留权益比例是否未 ...

证券代码：003000 证券简称：劲仔食品 公告编号：2025-045 劲仔食品集团股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示： 票回购专项贷款资金通过集中竞价交易方式回购公司部分股份。本次回购股份的 价格为不超过 16 元/股(含)，回购资金总额为不低于人民币 5,000 万元(含)、不超 过人民币 10,000 万元(含)，具体回购股份的数量以回购期限届满或者回购股份实 施完毕时实际回购的股份数量为准。回购期限为自公司董事会审议通过本次回购 方案之日起不超过 12 个月。本次回购股份后续将用作股权激励计划及/或员工持 股计划。 次会议审议通过。 人、持股 5%以上股东及其一致行动人、董事、高级管理人员在回购期间增减持 公司股份的计划，若未来相关主体拟实施股份增减持计划，公司将按照相关规定 及时履行信息披露义务。 （1）本次回购存在回购期限内公司股票价格持续超出回购价格上限，导致 回购方案无法实施或只能部分实施的风险。 （2）若对本公司股票交易价格产生重大影响的重大事项发生，或公司生产 经营、财务状况、外部客观情况发生重大变化 ...

Core Viewpoint - The company has completed the cancellation of stock options and the repurchase of restricted stocks due to unmet performance targets in the second vesting period of the stock incentive plan, resulting in a total of 2,901,000 stock options and restricted stocks being canceled and repurchased [1][2][3]. Group 1: Reasons for Cancellation and Repurchase - The cancellation of stock options and repurchase of restricted stocks were due to the company's failure to meet performance assessment requirements for the second vesting period, as verified by the audit reports [2][3]. - A total of 1,934,000 stock options and 1,934,000 restricted stocks were canceled, along with an additional 967,000 stock options and 967,000 restricted stocks related to the third vesting period [1][2]. Group 2: Details of the Cancellation and Repurchase - The decision to terminate the stock incentive plan and cancel the stock options was approved at the company's annual general meeting held on May 20, 2025 [1]. - The repurchase price for the restricted stocks was set at 9.84 yuan per share, plus accrued interest [1][2]. - The total number of repurchased and canceled restricted stocks amounts to 2,901,000 shares, with the completion of the cancellation expected by July 28, 2025 [4][5]. Group 3: Changes in Share Structure - Following the cancellation of stock options and repurchase of restricted stocks, the company's total share capital will decrease from 207,381,000 shares to 204,480,000 shares [4][5]. - The cancellation of stock options will not impact the company's share capital as they were not exercised [4]. Group 4: Legal Compliance and Commitments - The company has confirmed that all necessary approvals and disclosures have been made in accordance with legal regulations and internal policies regarding the stock incentive plan [6]. - The company has committed to handling any potential disputes arising from the repurchase and cancellation of stocks and will bear any related legal responsibilities [6].

Group 1 - Company Name: Shanxi Qianyuan Pharmaceutical Group Co., Ltd. [1] - Stock Code: 300254 [1] - Independent Financial Advisor: Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd. [1] Group 2 - Compliance with Listing Company Requirements: No negative or unable to express opinions in the audit report for the most recent financial year [3] - No violations of laws, regulations, or company articles regarding profit distribution in the last 36 months [3] - No major legal violations leading to administrative penalties or market bans by the China Securities Regulatory Commission in the last 12 months [3] Group 3 - Stock Incentive Plan Compliance: Total number of shares involved in all effective stock incentive plans does not exceed 20% of the company's total share capital [4] - The proportion of reserved rights for incentive objects does not exceed 20% of the proposed granted rights [4] - The plan includes detailed disclosures regarding the incentive objects, including names, positions, and granted quantities [4][5] Group 4 - Performance Assessment Indicators: Indicators are objective, public, clear, and beneficial for enhancing the company's competitiveness [5] - The plan's effective period, authorization date, and lock-up arrangements are clearly defined [4][6] - The company has not provided financial assistance to incentive objects [8]

Core Viewpoint - The company announced the cancellation of 660,960 stock options due to the failure to meet the performance conditions for the third exercise period of the 2022 equity incentive plan [1][5][6] Group 1: Decision Process and Disclosure - The company held board and supervisory meetings to review and approve the equity incentive plan and related proposals, ensuring compliance with decision-making procedures and information disclosure [1][2] - The independent directors provided their consent to the relevant proposals, and the list of incentive objects was publicly disclosed without objections from employees during the public notice period [2][3] Group 2: Reasons for Stock Option Cancellation - The cancellation of stock options was based on the failure to meet the performance assessment targets outlined in the incentive plan, specifically due to the company's revenue not reaching the required levels [5][6] - The company's revenue for the year was reported at approximately 534.24 million yuan, reflecting a growth rate of 55.20% compared to 344.23 million yuan in the previous year, but still not meeting the necessary performance criteria [5] Group 3: Impact of Cancellation - The cancellation of stock options is in accordance with relevant regulations and will not have a significant impact on the company's financial status or operational results [6] - The remuneration and assessment committee confirmed that the cancellation process was legal and compliant, and it will not adversely affect the stability of the management team or the interests of shareholders [6] Group 4: Legal Opinions - The company's actions regarding the adjustment of stock option exercise prices and the cancellation of options have received the necessary approvals and are in compliance with applicable regulations [6]

北京万集科技股份有限公司 章 程 第一章 总则 第一条 为维护北京万集科技股份有限公司（以下简称"公司"）、股东和 债权人的合法权益，规范公司的组织和行为，根据《中华人民共和国公司法》 （以下简称"《公司法》"）《中华人民共和国证券法》（以下简称"《证券 法》"）和其他有关规定，制订本章程。 第二条 公司系依照《公司法》《证券法》和其他有关规定成立的股份有限 公司。 公司由原北京万集科技有限责任公司全体股东共同作为发起人，以原北京万 集科技有限责任公司 2011 年 5 月 31 日为基准日的净资产折股进行整体变更的 方式设立。 公司于 2011 年 9 月 27 日在北京市工商行政管理局注册登记，取得营业执 照，营业执照号码为 110108004603106。 第三条 公司于 2016 年 9 月 23 日经中国证券监督管理委员会（以下简称 "中国证监会"）核准，首次向社会公众发行人民币普通股 2,670 万股，于 2016 年 10 月 21 日在深圳证券交易所（以下简称"证券交易所"）上市。 第四条 公司注册名称： 中文全称：北京万集科技股份有限公司 英文全称：VanJee Technology Co. ...

Group 1 - The company held its 11th meeting of the 3rd Supervisory Board on July 18, 2025, with all 3 supervisors present, confirming compliance with legal and regulatory requirements [2] - The Supervisory Board approved the conditions for the first unlock period of the 2024 restricted stock and stock option incentive plan, allowing 132 individuals to unlock 923,560 shares and exercise 914,760 stock options [2][3] - The Board also approved the repurchase and cancellation of 35,640 restricted stocks and stock options due to the departure of 2 incentive plan participants and the performance of 1 participant being deemed "qualified" [3][4] Group 2 - The Supervisory Board agreed to adjust the repurchase price of restricted stocks and the exercise price of stock options under the 2024 incentive plan, confirming that the adjustments comply with relevant regulations [4] - The Board approved adjustments to the 2025 employee stock ownership plan, ensuring that the changes are within the authorized scope and do not harm the interests of the company and its shareholders [5] - The chairman of the Supervisory Board recused himself from voting on the employee stock ownership plan adjustments [5]

Core Viewpoint - The legal opinion letter from Guangdong Xinda Law Firm confirms that Wanze Industrial Co., Ltd. has obtained the necessary approvals and authorizations for its 2025 equity incentive plan, which includes the granting of restricted stocks to eligible participants [6][10][12]. Group 1: Legal Framework and Approvals - The equity incentive plan is in compliance with relevant laws, including the Company Law, Securities Law, and the Management Measures for Equity Incentives of Listed Companies [6][10]. - The plan was approved by the company's Board of Directors and Supervisory Board, indicating a consensus on its benefits for corporate governance and employee motivation [7][10]. - The plan's implementation is deemed beneficial for the company's sustainable development and does not harm the interests of the company or its shareholders [7][10]. Group 2: Granting Conditions and Procedures - The granting date for the restricted stocks is set for July 17, 2025, with a price of 7.35 yuan per share, totaling 5.7225 million shares for 217 participants [10][12]. - The plan stipulates specific conditions that must be met for the granting of restricted stocks, including the absence of certain negative events affecting the company or the participants [12][15]. - The company has conducted necessary disclosures and verifications to ensure compliance with the regulations governing insider trading and eligibility of the incentive recipients [9][10]. Group 3: Conclusion and Next Steps - The legal opinion concludes that all necessary approvals have been obtained, and the conditions for granting the restricted stocks have been satisfied [15]. - The company is required to fulfill its information disclosure obligations and complete the registration of the stock grants as per regulatory requirements [15].

万泽实业股份有限公司（以下简称"公司"）于2025年6月27日召开第十 一届董事会第四十九次会议及第十一届监事会第二十九次会议，审议通过 了《 <公司2025年股权激励计划 草案="草案"> 及其摘要的议案》等议案，并于 信息披露网站上披露了相关公告。 根据中国证监会《上市公司股权激励管理办法》、深圳证券交易所《深 圳证券交易所上市公司自律监管指南第1号——业务办理》等相关法律、法 规、规范性文件的要求，通过向中国证券登记结算有限责任公司深圳分公司 （以下简称"中国结算深圳分公司"）查询，公司对本次激励计划内幕信息 知情人在公司2025年股权激励计划（以下简称"本次激励计划"）草案披露 前六个月内买卖本公司股票的情况进行自查，具体情况如下： 一、核查范围及程序 知情人范围，并对所有内幕信息知情人进行登记、填报于《内幕信息知情人 登记表》。 案公开披露前六个月（即2024年12月27日——2025年6月27日，以下简称"自 查期间"）买卖公司股票的情况进行了查询，并取得中国结算深圳分公司出 具的书面查询结果。 证券代码：000534 证券简称：万泽股份 公告编号:2025-064 万泽实业股份有限公司 关于公司 ...

Core Viewpoint - Midea Group has announced the commencement of the third exercise period for its eighth stock option incentive plan, with a total of 19,722,008 stock options eligible for exercise by 1,255 incentive targets [1][7][10]. Group 1: Stock Option Plan Details - The eighth stock option incentive plan was approved at the 2020 annual general meeting, allowing for the granting of stock options to 1,901 incentive targets, totaling 82.48 million options at an exercise price of 82.98 yuan per share [2][3]. - The exercise price has been adjusted multiple times, currently set at 70.78 yuan per share for the third exercise period [10][12]. - The total number of stock options has been adjusted from 82.48 million to 81.74 million due to changes in the list of incentive targets [3][5]. Group 2: Exercise Conditions and Compliance - The exercise conditions for the third period have been met, with no disqualifying events occurring for the company or the incentive targets [7][12]. - The incentive targets must have achieved performance assessments that are not rated as "poor" in the previous two years to be eligible for exercising options [9][12]. - The company has established compliance measures to ensure that the exercise of options does not occur during sensitive periods, such as before financial report announcements [12][13]. Group 3: Financial Implications - If all eligible options are exercised, the company's total share capital will increase by 19,722,008 shares, resulting in an increase in shareholder equity by approximately 1.396 billion yuan [14]. - The funds raised from the exercise of options will be stored in a designated bank account and used to supplement the company's working capital [14]. Group 4: Future Disclosure Arrangements - The company will disclose the status of stock option exercises, changes in incentive targets, and adjustments to stock option parameters in its semi-annual and annual reports [14].